Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
NCT06451770
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypercholesterolemia
Hypertriglyceridemia
Refractory Hyperlipidemia
Interventions
DRUG:
VERVE-201
Sponsor
Verve Therapeutics, Inc.